Beauty and fashion

Designer Virginie Viard accepts applause at the end of the Chanel Haute Couture Fall-Winter 2020 fashion collection presented in Paris, Tuesday, July 2 2019. (AP Photo/Michel Euler)
July 02, 2019 - 4:58 pm
PARIS (AP) — Chanel's new chief Virginie Viard merged the worlds of two of its most famous couturiers, those of Gabrielle "Coco" Chanel and Karl Lagerfeld, for a cerebral couture show in Paris set inside a huge circular library. For Viard's first-ever solo couture show, both Chanel, the woman, and...
Read More
Designer Virginie Viard accepts applause at the end of the Chanel Haute Couture Fall-Winter 2020 fashion collection presented in Paris, Tuesday, July 2 2019. (AP Photo/Michel Euler)
July 02, 2019 - 3:46 pm
PARIS (AP) — Chanel's new chief Virginie Viard merged the worlds of two of its most famous couturiers, those of Gabrielle "Coco" Chanel and Karl Lagerfeld, for a cerebral couture show in Paris set inside a huge circular library. For Viard's first-ever solo couture show, both Chanel, the woman, and...
Read More
A model wears a creation for the Chanel Haute Couture Fall-Winter 2020 fashion collection presented in Paris, Tuesday, July 2 2019. (AP Photo/Michel Euler)
July 02, 2019 - 3:04 pm
PARIS (AP) — Chanel's new chief Virginie Viard merged the worlds of two of its most famous couturiers, those of Gabrielle "Coco" Chanel and Karl Lagerfeld, for a cerebral couture show in Paris set inside a huge circular library. For Viard's first-ever solo couture show, both Chanel, the woman, and...
Read More
A model wears a creation for Iris van Herpen Haute Couture Fall-Winter 2019-2020 fashion collection presented in Paris, Monday, July 1 2019. (AP Photo/Francois Mori)
July 01, 2019 - 2:40 pm
PARIS (AP) — Dior went back to the essential architecture of dressmaking, and the late designer's penchant for black, for a brooding display Monday of archetypally couture fall-winter gowns. Looking on inside the Parisian house's design studios Monday on Avenue Montaigne were Gal Gadot, Elisabeth...
Read More
Jimmy Kilgore, left, and Victor Voss pose for a photo with the Auburn University class ring that Voss had lost years ago. Kilgore's father had found the ring years ago and saved it until Kilgore came across the ring and decided to find the original owner. (Jay Hare/Dothan Eagle via AP)
June 26, 2019 - 5:39 pm
DOTHAN, Ala. (AP) — A man has been reunited with the Auburn University class ring he lost most than 50 years ago. The Dothan Eagle reports 74-year-old Victor Voss got his ring back Monday. Voss says he was wearing the ring over his gloves on a cold day in 1966 because it was too large for his...
Read More
In this June 5, 2009, photo a woman has Botox injected at Reveal in Arlington, Va. AbbVie is buying Botox maker Allergan in a cash-and-stock deal the drugmakers value at around $63 billion. The maker of the blockbuster immune disorder treatment Humira said Tuesday, June 25, 2019, that it will pay $120.30 in cash and a portion of AbbVie stock for each Allergan share. (AP Photo/Jacquelyn Martin, File)
June 25, 2019 - 2:39 pm
Facing competition for the world's top-selling drug, AbbVie is jumping on this year's pharmaceutical merger bandwagon with a $63 billion bid for Botox maker Allergan that's meant to spur future growth. Specialty drugmaker AbbVie said Tuesday that adding Allergan's aesthetics products and eye care...
Read More
A man looks at a Bulgari necklace and earrings in gold with diamonds from 1969 during a preview of the exhibition "Bulgari. The story, the dream" at St. Angel Castle in Rome, Tuesday, June 25, 2019. The exhibition, which is on from June 26 till Nov. 3, 2019 features jewels and vintage haute couture pieces owned and worn by legendary actresses like, ElizabethTaylor, Ingrid Bergman, Sophia Loren, Gina Lollobrigida and Audrey Hepburn. (AP Photo/Domenico Stinellis)
June 25, 2019 - 12:38 pm
ROME (AP) — Glamorous jewelry and vintage fashion from the "La Dolce Vita" era are the star attractions of Bulgari's new exhibition in Rome. The exhibition "Bvlgari, the story, the dream" includes the diamond-and-sapphire sautoir necklace that Hollywood star Richard Burton gave Elizabeth Taylor...
Read More
A man looks at a Bulgari necklace and earrings in gold with diamonds from 1969 during a preview of the exhibition "Bulgari. The story, the dream" at St. Angel Castle in Rome, Tuesday, June 25, 2019. The exhibition, which is on from June 26 till Nov. 3, 2019 features jewels and vintage haute couture pieces owned and worn by legendary actresses like, ElizabethTaylor, Ingrid Bergman, Sophia Loren, Gina Lollobrigida and Audrey Hepburn. (AP Photo/Domenico Stinellis)
June 25, 2019 - 11:20 am
ROME (AP) — Glamorous jewelry and vintage fashion from the "La Dolce Vita" era are the star attractions of Bulgari's new exhibition in Rome. The exhibition "Bvlgari, the story, the dream" includes the diamond-and-sapphire sautoir necklace that Hollywood star Richard Burton gave Elizabeth Taylor...
Read More
In this June 5, 2009, photo a woman has Botox injected at Reveal in Arlington, Va. AbbVie is buying Botox maker Allergan in a cash-and-stock deal the drugmakers value at around $63 billion. The maker of the blockbuster immune disorder treatment Humira said Tuesday, June 25, 2019, that it will pay $120.30 in cash and a portion of AbbVie stock for each Allergan share. (AP Photo/Jacquelyn Martin, File)
June 25, 2019 - 10:51 am
Facing competition for the world's top-selling drug, AbbVie will spend about $63 billion to buy Botox maker Allergan as it attempts to spur future growth. The specialty drugmaker said Tuesday that the addition of Allergan's established product lineup will help AbbVie shore up revenue as near-...
Read More
FILE - This Jan. 24, 2015, file photo, shows the exterior of AbbVie, in Lake Bluff, Ill. AbbVie is buying Botox maker Allergan in a cash-and-stock deal the drugmakers value at around $63 billion. The maker of the blockbuster immune disorder treatment Humira said Tuesday, June 25, 2019, that it will pay $120.30 in cash and a portion of AbbVie stock for each Allergan share. (AP Photo/Nam Y. Huh, File)
June 25, 2019 - 8:19 am
The specialty drug company AbbVie will spend $63 billion to acquire Allergan, the maker of Botox and other cosmetic treatments. The two pharmaceutical companies have little in common, save for a desire to reinvigorate growth that has sputtered. Shares of AbbVie are down 16% over the past year and...
Read More

Pages